Entera Bio (ENTX) Prepaid Assets (2017 - 2026)
Entera Bio (ENTX) posted quarterly Prepaid Assets of $566000.0 for Q1 2026, up 9.06% year-on-year from $519000.0 in Q1 2025, and up 36.39% on a QoQ basis from $415000.0 in Q4 2025.
Entera Bio (ENTX) Prepaid Assets (2017 - 2026) Analysis & Trends
Entera Bio (ENTX) has reported Prepaid Assets for 10 consecutive years, with $566000.0 the latest figure, recorded in Q1 2026.
- Quarterly Prepaid Assets rose 9.06% year-over-year to $566000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $566000.0 (up 9.06% YoY) and the FY2025 annual result came in at $415000.0, up 123.12% from the prior year.
- Prepaid Assets advanced to $566000.0 in Q1 2026 per ENTX's latest filing, from $415000.0 in the prior quarter.
- Over the last five years, Prepaid Assets for ENTX reached as high as $1.3 million in Q1 2022 and fell as low as $186000.0 in Q4 2024.
- A 5-year average of $535294.1 and a median of $482000.0 in 2024 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2023 — Prepaid Assets tumbled 50.61% — and 2025, when it surged 123.12%.
- Year by year, Prepaid Assets stood at $294000.0 in 2022, then fell by 19.05% to $238000.0 in 2023, then declined by 21.85% to $186000.0 in 2024, then surged by 123.12% to $415000.0 in 2025, then surged by 36.39% to $566000.0 in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $566000.0, $415000.0, and $405000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Entera Bio | 186.78 Mn | 182.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 566,000.00 |
| Dec 31, 2025 | 415,000.00 |
| Sep 30, 2025 | 405,000.00 |
| Jun 30, 2025 | 438,000.00 |
| Mar 31, 2025 | 519,000.00 |
| Dec 31, 2024 | 186,000.00 |
| Sep 30, 2024 | 383,000.00 |
| Jun 30, 2024 | 482,000.00 |
| Mar 31, 2024 | 562,000.00 |
| Dec 31, 2023 | 238,000.00 |
| Sep 30, 2023 | 431,000.00 |
| Jun 30, 2023 | 650,000.00 |
| Mar 31, 2023 | 653,000.00 |
| Dec 31, 2022 | 294,000.00 |
| Sep 30, 2022 | 634,000.00 |
| Jun 30, 2022 | 922,000.00 |
| Mar 31, 2022 | 1.32 Mn |
| Dec 31, 2021 | 254,000.00 |
| Dec 31, 2020 | 261,000.00 |
| Dec 31, 2019 | 97,000.00 |